Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125610621 | 12561062 | 1 | I | 2016 | 20160620 | 20160715 | 20160715 | EXP | PHHY2016US089821 | SANDOZ | 0.00 | F | Y | 0.00000 | 20160715 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125610621 | 12561062 | 1 | SS | LIORESAL | BACLOFEN | 1 | Intrathecal | 630.6 UG, QD | DS0083 | 0 | 630.6 | UG | AMPOULE | QD | |||||
| 125610621 | 12561062 | 2 | SS | LIORESAL | BACLOFEN | 1 | 0 | AMPOULE | |||||||||||
| 125610621 | 12561062 | 3 | SS | BACLOFEN. | BACLOFEN | 1 | Oral | 20 MG, QID | U | 0 | 20 | MG | QID | ||||||
| 125610621 | 12561062 | 4 | PS | ALBUTEROL SULFATE TABLETS USP | ALBUTEROL SULFATE | 1 | Unknown | UNK | U | 72151 | |||||||||
| 125610621 | 12561062 | 5 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125610621 | 12561062 | 6 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125610621 | 12561062 | 7 | SS | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 600 MG, QID | U | 0 | 600 | MG | QID | ||||||
| 125610621 | 12561062 | 8 | SS | NABUMETONE. | NABUMETONE | 1 | Unknown | 750 MG, BID | U | 0 | 750 | MG | BID | ||||||
| 125610621 | 12561062 | 9 | SS | DIAZEPAM. | DIAZEPAM | 1 | Unknown | 5 MG, QID | U | 0 | 5 | MG | QID | ||||||
| 125610621 | 12561062 | 10 | SS | MYRBETRIQ | MIRABEGRON | 1 | Unknown | UNK | U | 0 | |||||||||
| 125610621 | 12561062 | 11 | SS | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Unknown | 600 MG, TID | U | 0 | 600 | MG | TID | ||||||
| 125610621 | 12561062 | 12 | SS | OXYCODONE | OXYCODONE | 1 | Unknown | UNK UNK, PRN (AS NEEDED) | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125610621 | 12561062 | 1 | Secondary progressive multiple sclerosis |
| 125610621 | 12561062 | 2 | Muscle spasticity |
| 125610621 | 12561062 | 3 | Product used for unknown indication |
| 125610621 | 12561062 | 4 | Product used for unknown indication |
| 125610621 | 12561062 | 5 | Product used for unknown indication |
| 125610621 | 12561062 | 6 | Product used for unknown indication |
| 125610621 | 12561062 | 7 | Product used for unknown indication |
| 125610621 | 12561062 | 8 | Product used for unknown indication |
| 125610621 | 12561062 | 9 | Product used for unknown indication |
| 125610621 | 12561062 | 10 | Product used for unknown indication |
| 125610621 | 12561062 | 11 | Product used for unknown indication |
| 125610621 | 12561062 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125610621 | 12561062 | OT |
| 125610621 | 12561062 | LT |
| 125610621 | 12561062 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125610621 | 12561062 | Blood sodium decreased | |
| 125610621 | 12561062 | Multiple sclerosis | |
| 125610621 | 12561062 | Therapeutic response changed | |
| 125610621 | 12561062 | Unresponsive to stimuli | |
| 125610621 | 12561062 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125610621 | 12561062 | 1 | 20160602 | 0 |